ES535097A0 - Procedimiento para la obtencion de complejos plantanidos de efecto modificador del contraste de una imagen rmn - Google Patents
Procedimiento para la obtencion de complejos plantanidos de efecto modificador del contraste de una imagen rmnInfo
- Publication number
- ES535097A0 ES535097A0 ES535097A ES535097A ES535097A0 ES 535097 A0 ES535097 A0 ES 535097A0 ES 535097 A ES535097 A ES 535097A ES 535097 A ES535097 A ES 535097A ES 535097 A0 ES535097 A0 ES 535097A0
- Authority
- ES
- Spain
- Prior art keywords
- plantanid
- complexes
- contrast
- procedure
- obtaining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title 1
- 238000012986 modification Methods 0.000 title 1
- 230000004048 modification Effects 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
- A61K49/10—Organic compounds
- A61K49/14—Peptides, e.g. proteins
- A61K49/16—Antibodies; Immunoglobulins; Fragments thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/003—Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Signal Processing (AREA)
- General Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Immunology (AREA)
- High Energy & Nuclear Physics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8313281A FR2550449B1 (fr) | 1983-08-12 | 1983-08-12 | Agents de relaxation specifiques d'organes ou de pathologies, utilisables pour modifier les contrastes en imagerie medicale par resonance magnetique nucleaire |
Publications (2)
Publication Number | Publication Date |
---|---|
ES535097A0 true ES535097A0 (es) | 1986-10-16 |
ES8700058A1 ES8700058A1 (es) | 1986-10-16 |
Family
ID=9291604
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES535097A Expired ES8700058A1 (es) | 1983-08-12 | 1984-08-10 | Procedimiento para la obtencion de complejos plantanidos de efecto modificador del contraste de una imagen rmn |
ES542928A Granted ES542928A0 (es) | 1983-08-12 | 1985-05-08 | Procedimiento para la obtencion de un complejo lantanido pa-ramagnetico de efecto modificador del contraste de una ima- gen medica por rmn. |
ES542927A Granted ES542927A0 (es) | 1983-08-12 | 1985-05-08 | Procedimiento para la obtencion de un complejo lantanido de efecto modificador del contraste de una imagen medica por rmn |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES542928A Granted ES542928A0 (es) | 1983-08-12 | 1985-05-08 | Procedimiento para la obtencion de un complejo lantanido pa-ramagnetico de efecto modificador del contraste de una ima- gen medica por rmn. |
ES542927A Granted ES542927A0 (es) | 1983-08-12 | 1985-05-08 | Procedimiento para la obtencion de un complejo lantanido de efecto modificador del contraste de una imagen medica por rmn |
Country Status (5)
Country | Link |
---|---|
US (1) | US4804529A (es) |
EP (1) | EP0133603A1 (es) |
JP (1) | JPS60100526A (es) |
ES (3) | ES8700058A1 (es) |
FR (1) | FR2550449B1 (es) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0330801A1 (en) * | 1983-02-08 | 1989-09-06 | Schering Aktiengesellschaft | Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |
US4735796A (en) * | 1983-12-08 | 1988-04-05 | Gordon Robert T | Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |
ZA852979B (en) * | 1984-04-27 | 1985-11-27 | Vestar Research Inc | Contrast agents for nmr imaging |
US4728575A (en) * | 1984-04-27 | 1988-03-01 | Vestar, Inc. | Contrast agents for NMR imaging |
US4687658A (en) * | 1984-10-04 | 1987-08-18 | Salutar, Inc. | Metal chelates of diethylenetriaminepentaacetic acid partial esters for NMR imaging |
SE465907B (sv) * | 1984-11-01 | 1991-11-18 | Nyegaard & Co As | Diagnosticeringsmedel innehaallande en paramagnetisk metall |
EP0184899B1 (en) * | 1984-11-01 | 1990-04-18 | Nycomed As | Paramagnetic contrast agents for use in "in vivo" diagnostic methods using nmr, and their preparation |
PT81498B (pt) * | 1984-11-23 | 1987-12-30 | Schering Ag | Processo para a preparacao de composicoes para diagnostico contendo particulas magneticas |
US4758422A (en) * | 1985-01-04 | 1988-07-19 | Salutar Inc. | Ferrioxamine paramagnetic contrast agents for MR imaging |
US5089644A (en) * | 1985-01-04 | 1992-02-18 | Salutar Inc. | Preparation of oxamine complexes |
US4986256A (en) * | 1985-02-28 | 1991-01-22 | The United States Of America As Represented By The Department Of Health And Human Services | Use of paramagnetic metalloporphyrins as contrast agents for tumors in MRI imaging |
US4880008A (en) * | 1985-05-08 | 1989-11-14 | The General Hospital Corporation | Vivo enhancement of NMR relaxivity |
US5422096A (en) * | 1985-05-08 | 1995-06-06 | The General Hospital Corporation | Hydroxy-aryl metal chelates for diagnostic NMR imaging |
US4899755A (en) * | 1985-05-08 | 1990-02-13 | The General Hospital Corporation | Hepatobiliary NMR contrast agents |
US4735210A (en) * | 1985-07-05 | 1988-04-05 | Immunomedics, Inc. | Lymphographic and organ imaging method and kit |
GB8518300D0 (en) * | 1985-07-19 | 1985-08-29 | Amersham Int Plc | Contrast agent |
MX174467B (es) * | 1986-01-23 | 1994-05-17 | Squibb & Sons Inc | 1,4,7-triscarboximetil-1,4,7,10-tetraazaciclodo decano substituido en 1 y compuestos analogos |
US4885363A (en) * | 1987-04-24 | 1989-12-05 | E. R. Squibb & Sons, Inc. | 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs |
IT1213029B (it) * | 1986-01-30 | 1989-12-07 | Bracco Ind Chimica Spa | Chelati di ioni metallici paramagnetici. |
GB8603537D0 (en) * | 1986-02-13 | 1986-03-19 | Parker D | Conjugate compound |
US5352432A (en) * | 1986-07-03 | 1994-10-04 | Advanced Magnetics, Inc. | Hepatocyte specific composition and their use as diagnostic imaging agents |
US5141739A (en) * | 1986-07-03 | 1992-08-25 | Advanced Magnetics, Inc. | Delivery of x-ray contrast agents using receptor mediated endocytosis |
US5554386A (en) * | 1986-07-03 | 1996-09-10 | Advanced Magnetics, Inc. | Delivery of therapeutic agents to receptors using polysaccharides |
US5679323A (en) * | 1986-07-03 | 1997-10-21 | Advanced Magnetics, Inc. | Hepatocyte-specific receptor-mediated endocytosis-type compositions |
US5284646A (en) * | 1986-07-03 | 1994-02-08 | Advanced Magnetics Inc. | Hepatocyte specific receptor mediated endocytosis type magnetic resonance imaging contrast agents |
US5039512A (en) * | 1986-08-04 | 1991-08-13 | Salutar, Inc. | NMR imaging with paramagnetic polyvalent metal salts of poly-(acid-alkylene-amino)-alkanes |
AU608759B2 (en) * | 1986-08-04 | 1991-04-18 | Amersham Health Salutar Inc | NMR imaging with paramagnetic polyvalents metal salts of poly-(acid-alkylene-amido)-alkanes |
US5219553A (en) * | 1986-08-04 | 1993-06-15 | Salutar, Inc. | Composition of a n-carboxymethylated tetraazacyclododecane chelating agent, a paramagnetic metal and excess calcium ions for MRI |
US5672334A (en) * | 1991-01-16 | 1997-09-30 | Access Pharmaceuticals, Inc. | Invivo agents comprising cationic metal chelators with acidic saccharides and glycosaminoglycans |
DE3709851A1 (de) * | 1987-03-24 | 1988-10-06 | Silica Gel Gmbh Adsorptions Te | Nmr-diagnostische fluessigkeitszusammensetzungen |
US5223538A (en) * | 1987-03-31 | 1993-06-29 | Duke University | Superoxide dismutase mimic |
JPS6456043A (en) * | 1987-08-27 | 1989-03-02 | Nippon Oil Co Ltd | Preparation of phantom for nmr diagnosis |
US5284647A (en) * | 1988-03-18 | 1994-02-08 | Schering Aktiengesellschaft | Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them |
GB8813425D0 (en) * | 1988-06-07 | 1988-07-13 | Hall L D | Magnetic resonance imaging |
WO1990001900A1 (en) * | 1988-08-24 | 1990-03-08 | The University Of Connecticut | Carrier system and method for enhancement of magnetic resonance imaging |
DE3834704A1 (de) * | 1988-10-07 | 1990-06-07 | Schering Ag | Fluorsubstituierte benzolderivate |
US5019370A (en) * | 1989-07-10 | 1991-05-28 | University Of Kentucky Research Foundation | Biodegradable, low biological toxicity radiographic contrast medium and method of x-ray imaging |
FR2654344B1 (fr) * | 1989-11-16 | 1994-09-23 | Cis Bio Int | Complexe paramagnetique de gadolinium, son procede de preparation et son utilisation pour le diagnostic par irm. |
US5516503A (en) * | 1989-11-16 | 1996-05-14 | Guerbet S.A. | Diagnostic composition comprising a binuclear complex, its method of preparation and its use in magnetic resonance imaging |
US5236695A (en) * | 1989-11-27 | 1993-08-17 | Concat, Ltd. | MRI image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands |
JP2593963B2 (ja) * | 1989-11-27 | 1997-03-26 | コンキャット リミティド | 常磁性カチオン及びポリホスホネートリガンドの錯体を用いての骨及び関連組織のmri像増強 |
US5154914A (en) * | 1990-03-12 | 1992-10-13 | Research Corporation Technologies, Inc. | Methods of diagnostic image analysis using lipophilic contrast agents |
DE4008179A1 (de) * | 1990-03-12 | 1991-09-19 | Schering Ag | Fluorbenzolsulfonamide |
US5242681A (en) * | 1990-03-12 | 1993-09-07 | Research Corporation Technologies, Inc. | Lipophilic contrast agents for diagnostic image analysis |
GB9006671D0 (en) * | 1990-03-24 | 1990-05-23 | Univ Manchester | Diagnostic method and compositions |
US5368840A (en) * | 1990-04-10 | 1994-11-29 | Imarx Pharmaceutical Corp. | Natural polymers as contrast media for magnetic resonance imaging |
US5143716A (en) * | 1991-02-01 | 1992-09-01 | Unger Evan C | Phosphorylated sugar alcohols, Mono- and Di-Saccharides as contrast agents for use in magnetic resonance imaging of the gastrointestinal region |
US5885549A (en) * | 1991-02-01 | 1999-03-23 | Imarx Pharmaceutical Corp. | Phosphorylated materials as contrast agents for use in magnetic resonance imaging of the gastrointestinal region |
US5169944A (en) * | 1991-04-12 | 1992-12-08 | Board Of Regents Of The University Of Washington | Methods and compositions for the enteral administration of hepatobiliary MRI contrast agents |
WO1992021017A1 (en) * | 1991-05-23 | 1992-11-26 | Unger Evan C | Liposoluble compounds for magnetic resonance imaging |
US5262532A (en) * | 1991-07-22 | 1993-11-16 | E.R. Squibb & Sons, Inc. | Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging |
EP0580878B1 (en) * | 1992-06-01 | 1996-01-10 | BASF Aktiengesellschaft | The use of dispersions of magneto-ionic particles as MRI contrast media |
DE69312951T2 (de) * | 1992-10-14 | 1997-12-11 | Nycomed Imaging As | Chelatpolymere |
US5817292A (en) * | 1992-10-14 | 1998-10-06 | Nycomed Imaging As | MR imaging compositions and methods |
ES2140469T3 (es) * | 1992-10-14 | 2000-03-01 | Nycomed Imaging As | Composiciones y metodos terapeuticos y de diagnostico por obtencion de imagenes. |
US5525324A (en) * | 1993-08-06 | 1996-06-11 | Block; Ronald E. | Organic silicon contrast agents and methods of use |
US5409689A (en) * | 1993-08-13 | 1995-04-25 | Concat, Ltd. | MRI image enhancement using complexes of paramagnetic cations and amine ligands containing a mixture of phosphonate and non-phosphonate pendant arms |
US5582814A (en) * | 1994-04-15 | 1996-12-10 | Metasyn, Inc. | 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging |
US6122540A (en) * | 1994-06-08 | 2000-09-19 | The Regents Of The University Of California | Noninvasive measurement of renal hemodynamic functions using magnetic resonance imaging |
GB9416768D0 (en) * | 1994-08-18 | 1994-10-12 | Nycomed Innovation Ab | Compositions |
US5863519A (en) * | 1994-08-18 | 1999-01-26 | Nycomed Imaging As | Composition and method of MRI using both a positive and a negative contrast agent |
TW319763B (es) | 1995-02-01 | 1997-11-11 | Epix Medical Inc | |
US5874573A (en) * | 1995-06-26 | 1999-02-23 | Concat, Inc. | Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy |
US5804164A (en) * | 1996-03-13 | 1998-09-08 | Research Corporation Technologies, Inc. | Water-soluble lipophilic contrast agents |
EP1031354A3 (en) | 1999-01-19 | 2003-02-05 | Rohm And Haas Company | Polymeric MRI Contrast agents |
FR2801299B1 (fr) * | 1999-11-23 | 2002-06-07 | Rhodia Terres Rares | Dispersion colloidale aqueuse a base d'au moins un compose d'un lanthanide et d'un complexant, procede de preparation et utilisation |
FR2867473B1 (fr) | 2004-03-12 | 2006-06-23 | Guerbet Sa | Compose de porphyrines et utilisation a haut champ en irm |
KR102263060B1 (ko) * | 2014-09-02 | 2021-06-09 | 삼성전자주식회사 | 금이온을 포함하는 이노시톨 폴리포스페이트 복합체, 및 그의 용도 및 제조방법 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2322M (fr) * | 1961-04-15 | 1964-02-10 | Richter Gedeon Vegyeszet | Complexes solubles dans l'eau des métaux du groupe du lanthane utilisables comme médicaments. |
US3789060A (en) * | 1971-11-03 | 1974-01-29 | Wisconsin Alumni Res Found | Fluorinated camphor derivatives and europium and praseodymium chelates thereof |
US4156683A (en) * | 1973-03-26 | 1979-05-29 | Schering Corporation | Complexes of macrocyclic compounds |
US4647447A (en) * | 1981-07-24 | 1987-03-03 | Schering Aktiengesellschaft | Diagnostic media |
DE3129906C3 (de) * | 1981-07-24 | 1996-12-19 | Schering Ag | Paramagnetische Komplexsalze, deren Herstellung und Mittel zur Verwendung bei der NMR-Diagnostik |
-
1983
- 1983-08-12 FR FR8313281A patent/FR2550449B1/fr not_active Expired
-
1984
- 1984-08-06 EP EP84401637A patent/EP0133603A1/fr not_active Withdrawn
- 1984-08-10 US US06/640,160 patent/US4804529A/en not_active Expired - Fee Related
- 1984-08-10 ES ES535097A patent/ES8700058A1/es not_active Expired
- 1984-08-13 JP JP59169176A patent/JPS60100526A/ja active Pending
-
1985
- 1985-05-08 ES ES542928A patent/ES542928A0/es active Granted
- 1985-05-08 ES ES542927A patent/ES542927A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
ES8603757A1 (es) | 1986-01-01 |
JPS60100526A (ja) | 1985-06-04 |
US4804529A (en) | 1989-02-14 |
ES542927A0 (es) | 1986-01-01 |
ES8603758A1 (es) | 1986-01-01 |
ES542928A0 (es) | 1986-01-01 |
EP0133603A1 (fr) | 1985-02-27 |
ES8700058A1 (es) | 1986-10-16 |
FR2550449A1 (fr) | 1985-02-15 |
FR2550449B1 (fr) | 1986-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES535097A0 (es) | Procedimiento para la obtencion de complejos plantanidos de efecto modificador del contraste de una imagen rmn | |
ES540044A0 (es) | Un procedimiento para la produccion de una imagen | |
AR222778A1 (es) | Procedimiento para la obtencion de hentriacontapeptidos | |
ES524707A0 (es) | Procedimiento para la produccion de una imagen. | |
ES551493A0 (es) | Procedimiento para la obtencion de productos intermedios para derivados de 5-amino-4-hidroxivalerilo sustituidos. | |
ES493029A0 (es) | Procedimiento para la obtencion de octapeptidos ciclicos | |
AU510545B2 (en) | Positron tomographic imaging | |
DE3483371D1 (de) | Abschirmung fuer optischen fuehler. | |
ES530647A0 (es) | Un procedimiento para la preparacion de una imagen | |
IT1116634B (it) | Apparecchio per la tomografia | |
ES529108A0 (es) | Procedimiento para la obtencion de derivados de la piridazina con accion psicotropa | |
ES491423A0 (es) | Procedimiento para la obtencion de soluciones conformables | |
ES521865A0 (es) | Procedimiento de producir derivados oxazolicos. | |
ES488717A0 (es) | Procedimiento para la obtencion de derivados de pirazol | |
MX7349E (es) | Procedimiento mejorado para producir proteina unicelular | |
ES532240A0 (es) | Procedimiento para la obtencion de benzoil-ureas. | |
IT1178827B (it) | Monocromatore con ricostruzione delle immagini | |
ES532485A0 (es) | Procedimiento para producir derivados de tiatriazina | |
MX147828A (es) | Procedimiento mejorado para la obtencion de butanodioles | |
ES549384A0 (es) | Procedimiento para la obtencion de derivados del 2-aminome- til-2-penem. | |
ES531516A0 (es) | Procedimiento para la obtencion de una (5 )-20-espirox-1-en-3-ona | |
ES502355A0 (es) | Procedimiento para la obtencion de nuevos derivados del ben-zazol | |
MX5095E (es) | Procedimiento mejorado de obtencion de derivados del tiocromano | |
ES528109A0 (es) | Procedimiento para la obtencion del 2,4,6 triyodofenol | |
DOP1980002934A (es) | Procedimiento para la obtencion de derivados de triazol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19970401 |